0001193125-23-282236.txt : 20231122 0001193125-23-282236.hdr.sgml : 20231122 20231122160532 ACCESSION NUMBER: 0001193125-23-282236 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231120 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aligos Therapeutics, Inc. CENTRAL INDEX KEY: 0001799448 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39617 FILM NUMBER: 231433418 BUSINESS ADDRESS: STREET 1: ONE CORPORATE DR., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (800) 466-6059 MAIL ADDRESS: STREET 1: ONE CORPORATE DR., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 d589765d8k.htm 8-K 8-K
false 0001799448 0001799448 2023-11-20 2023-11-20

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 20, 2023

 

 

Aligos Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39617   82-4724808

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification Number)

One Corporate Dr., 2nd Floor

South San Francisco, CA 94080

(Address of principal executive offices, including Zip Code)

(800) 466-6059

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol

  

Name of each exchange
on which registered

Common Stock, $0.0001 par value per share   ALGS  

The Nasdaq Stock Market LLC

(Nasdaq Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 20, 2023, in connection with the previously disclosed resignation of Leonid Beigelman, President of Aligos Therapeutics, Inc. (the “Company”), the Company and Dr. Beigelman entered into a separation and release agreement (the “Separation Agreement”), containing a general release of claims and standard restrictive covenants. Pursuant to the Separation Agreement, Dr. Beigelman will be eligible to receive certain severance benefits, including the payment of an amount equal to 6 months of his current base salary and the continuation of his health coverage pursuant to COBRA at the Company’s expense for a period of 12 months following his last day of employment.

The foregoing description of the separation and release agreement with Dr. Beigelman is qualified in its entirety by reference to the separation and release agreement, which will be filed as an exhibit to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ALIGOS THERAPEUTICS, INC.
Date: November 22, 2023     By:  

/s/ Lesley Ann Calhoun

      Lesley Ann Calhoun
      Executive Vice President, Chief Financial Officer
 EX-101.SCH 2 algs-20231120.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 algs-20231120_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 algs-20231120_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information
Nov. 20, 2023
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001799448
Document Type 8-K
Document Period End Date Nov. 20, 2023
Entity Registrant Name Aligos Therapeutics, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-39617
Entity Tax Identification Number 82-4724808
Entity Address, Address Line One One Corporate Dr.
Entity Address, Address Line Two 2nd Floor
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (800)
Local Phone Number 466-6059
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol ALGS
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
XML 6 d589765d8k_htm.xml IDEA: XBRL DOCUMENT 0001799448 2023-11-20 2023-11-20 false 0001799448 8-K 2023-11-20 Aligos Therapeutics, Inc. DE 001-39617 82-4724808 One Corporate Dr. 2nd Floor South San Francisco CA 94080 (800) 466-6059 false false false false Common Stock, $0.0001 par value per share ALGS NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"% ,4 " "O@'9799!YDAD! #/ P $P @ '>$@ I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" H% ! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports algs-20231120.xsd algs-20231120_lab.xml algs-20231120_pre.xml d589765d8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d589765d8k.htm": { "nsprefix": "algs", "nsuri": "http://dfinsolutions.com/20231120", "dts": { "schema": { "local": [ "algs-20231120.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "algs-20231120_lab.xml" ] }, "presentationLink": { "local": [ "algs-20231120_pre.xml" ] }, "inline": { "local": [ "d589765d8k.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2023-11-20_to_2023-11-20", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d589765d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2023-11-20_to_2023-11-20", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d589765d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://dfinsolutions.com//20231120/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001193125-23-282236-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-282236-xbrl.zip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end